Clinical Report: Utilization of Prone Positioning for Patients with ARDS
Overview
Prone positioning (PP) is an intervention in managing ARDS, showing benefits in intubated patients. Its application has expanded to non-intubated patients during the COVID-19 pandemic.
Background
Prone positioning has transitioned from a rescue maneuver to a component of ARDS management, supported by evidence. It enhances oxygenation and reduces ventilator-induced lung injury by improving lung mechanics and gas exchange. The uptake of PP varies across healthcare settings.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
PP improves oxygenation in intubated patients with moderate-to-severe ARDS.
The PROSEVA trial demonstrated a reduction in 28-day mortality with early and prolonged PP.
Awake prone positioning (APP) has shown effects in non-intubated patients during the COVID-19 pandemic.
Implementation of PP varies despite guideline recommendations.
Physiological benefits of PP include improved ventilation-perfusion matching.
Clinical Implications
Healthcare professionals should consider the integration of prone positioning into management protocols for ARDS patients.
Conclusion
Prone positioning is an intervention in ARDS management, with evidence supporting its efficacy in intubated patients.
Protection against spread appeared strongest within 6 months of vaccination, while exposed vaccinated contacts showed no measurable reduction in infection risk.
